Calutide

an oral product from Cipla

Calutide by Cipla is an oral medication containing 50 mg of Bicalutamide per film-coated tablet. It is used in the treatment of prostate gland cancer, specifically in combination with luteinizing hormone-releasing hormone (LNRH) for stage D2 metastatic prostate cancer. The product is available in pack sizes of 30, 60, and 90 tablets. The generic name for Calutide is Bicalutamide, and it is also known under the US brand name Casodex.